-
Blanc M, Hsieh W, Robertson K, Watterson S, Shui G, Lacaze P, Khondoker M, Dickinson P, Sing G, Rodríguez-Martín S, Phelan P, Forster T, Strobl B, Müller M, Riemersma R, Osborne T, Wenk M, Angulo A, Ghazal P, 2011: Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis[J]. PLoS Biol, 9, e1000598-. doi: 10.1371/journal.pbio.1000598
-
Bordier B, Ohkanda J, Liu P, Lee S, Salazar F, Marion P, Ohashi K, Meuse L, Kay M, Casey J, Sebti S, Hamilton A, Glenn J, 2003: In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus[J]. J Clin Investig, 112, 407-414. doi: 10.1172/JCI17704
-
Borghese F, Michiels T, 2011: The leader protein of cardioviruses inhibits stress granule assembly[J]. J Virol, 85, 9614-9622. doi: 10.1128/JVI.00480-11
-
Bracht A, O'Hearn E, Fabian A, Barrette R, Sayed A, 2016: Real-time reverse transcription PCR assay for detection of senecavirus a in swine vesicular diagnostic specimens[J]. PLoS ONE, 11, e0146211-. doi: 10.1371/journal.pone.0146211
-
Chen Y, Wang S, Yi Z, Tian H, Aliyari R, Li Y, Chen G, Liu P, Zhong J, Chen X, Du P, Su L, Qin F, Deng H, Cheng G, 2014: Interferon-inducible cholesterol-25-hydroxylase inhibits hepatitis C virus replication via distinct mechanisms[J]. Sci Rep, 4, 7242-.
-
Civra A, Cagno V, Donalisio M, Biasi F, Leonarduzzi G, Poli G, Lembo D, 2014: Inhibition of pathogenic non-enveloped viruses by 25-hydroxycholesterol and 27-hydroxycholesterol[J]. Sci Rep, 4, 7487-.
-
Clark P, Thompson A, Vock D, Kratz L, Tolun A, Muir A, McHutchison J, Subramanian M, Millington D, Kelley R, Patel K, 2012: Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner[J]. Hepatology, 56, 49-56.
-
del Real G, Jiménez-Baranda S, Mira E, Lacalle R, Lucas P, Gómez-Moutón C, Alegret M, Peña J, Rodríguez-Zapata M, Alvarez-Mon M, Martínez-A C, Mañes S, 2004: Statins inhibit HIV-1 infection by down-regulating Rho activity[J]. J Exp Med, 200, 541-547. doi: 10.1084/jem.20040061
-
Desplanques A, Nauwynck H, Vercauteren D, Geens T, Favoreel H, 2008: Plasma membrane cholesterol is required for efficient pseudorabies virus entry[J]. Virology, 376, 339-345. doi: 10.1016/j.virol.2008.03.039
-
Fernández J, Agüero M, Romero L, Sánchez C, Belák S, Arias M, Sánchez-Vizcaíno J, 2008: Rapid and differential diagnosis of foot-and-mouth disease, swine vesicular disease, and vesicular stomatitis by a new multiplex RT-PCR assay[J]. J Virol Methods, 147, 301-311. doi: 10.1016/j.jviromet.2007.09.010
-
Gold E, Diercks A, Podolsky I, Podyminogin R, Askovich P, Treuting P, Aderem A, 2014: 25-Hydroxycholesterol acts as an amplifier of inflammatory signaling[J]. Proc Natl Acad Sci USA, 111, 10666-10671. doi: 10.1073/pnas.1404271111
-
Hales L, Knowles N, Reddy P, Xu L, Hay C, Hallenbeck P, 2008: Complete genome sequence analysis of Seneca Valley virus-001, a novel oncolytic picornavirus[J]. J Gen Virol, 89, 1265-1275. doi: 10.1099/vir.0.83570-0
-
Janowski B, Grogan M, Jones S, Wisely G, Kliewer S, Corey E, Mangelsdorf D, 1999: Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta[J]. Proc Natl Acad Sci USA, 96, 266-271. doi: 10.1073/pnas.96.1.266
-
Kandutsch A, Chen H, Heiniger H, 1978: Biological activity of some oxygenated sterols[J]. Science, 201, 498-501. doi: 10.1126/science.663671
-
Koarai A, Yanagisawa S, Sugiura H, Ichikawa T, Kikuchi T, Furukawa K, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M, 2012: 25-Hydroxycholesterol enhances cytokine release and Toll-like receptor 3 response in airway epithelial cells[J]. Respir Res, 13, 63-. doi: 10.1186/1465-9921-13-63
-
Leme R, Zotti E, Alcântara B, Oliveira M, Freitas L, Alfieri A, Alfieri A, 2015: Senecavirus A: an emerging vesicular infection in Brazilian pig herds[J]. Transbound Emerg Dis, 62, 603-611. doi: 10.1111/tbed.12430
-
Leme R, Oliveira T, Alfieri A, Headley S, Alfieri A, 2016: Pathological, immunohistochemical and molecular findings associated with senecavirus A-induced lesions in neonatal piglets[J]. J Comp Pathol, 155, 145-155. doi: 10.1016/j.jcpa.2016.06.011
-
Li C, Deng Y, Wang S, Ma F, Aliyari R, Huang X, Zhang N, Watanabe M, Dong H, Liu P, Li X, Ye Q, Tian M, Hong S, Fan J, Zhao H, Li L, Vishlaghi N, Buth J, Au C, Liu Y, Lu N, Du P, Qin F, Zhang B, Gong D, Dai X, Sun R, Novitch B, Xu Z, Qin C, Cheng G, 2017: 25-Hydroxycholesterol protects host against zika virus infection and its associated microcephaly in a mouse model[J]. Immunity, 46, 446-456. doi: 10.1016/j.immuni.2017.02.012
-
Liu S, Aliyari R, Chikere K, Li G, Marsden M, Smith J, Pernet O, Guo H, Nusbaum R, Zack J, Freiberg A, Su L, Lee B, Cheng G, 2013: Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol[J]. Immunity, 38, 92-105. doi: 10.1016/j.immuni.2012.11.005
-
Lund E, Kerr T, Sakai J, Li W, Russell D, 1998: cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism[J]. J Biol Chem, 273, 34316-34327. doi: 10.1074/jbc.273.51.34316
-
Lung O, Fisher M, Beeston A, Hughes K, Clavijo A, Goolia M, Pasick J, Mauro W, Deregt D, 2011: Multiplex RT-PCR detection and microarray typing of vesicular disease viruses[J]. J Virol Methods, 175, 236-245. doi: 10.1016/j.jviromet.2011.05.023
-
Lv LX, Zhao GM, Wang HM, He HB, 2019: Cholesterol 25-Hydroxylase inhibits bovine parainfluenza virus type 3 replication through enzyme activity-dependent and -independent ways[J]. Vet Microbiol, 239, 108456-. doi: 10.1016/j.vetmic.2019.108456
-
Munger J, Bennett B, Parikh A, Feng X, McArdle J, Rabitz H, Shenk T, Rabinowitz J, 2008: Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy[J]. Nat Biotechnol, 26, 1179-1186. doi: 10.1038/nbt.1500
-
Park K, Scott A, 2010: Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type Ⅰ interferons[J]. J Leukoc Biol, 88, 1081-1087. doi: 10.1189/jlb.0610318
-
Qian S, Fan W, Qian P, Chen H, Li X, 2016: Isolation and full-genome sequencing of Seneca Valley virus in piglets from China, 2016[J]. Virology journal, 13, 173-. doi: 10.1186/s12985-016-0631-2
-
Qian S, Fan W, Liu T, Wu M, Zhang H, Cui X, Zhou Y, Hu J, Wei S, Chen H, Li X, Qian P, 2017: Seneca Valley virus suppresses host type Ⅰ interferon production by targeting adaptor proteins MAVS, TRIF, and TANK for cleavage[J]. J Virol, 91, 17-.
-
Raniga K, Liang C, 2018: Interferons: reprogramming the metabolic network against viral infection[J]. Viruses, 10, 36-. doi: 10.3390/v10010036
-
Reboldi A, Dang E, McDonald J, Liang G, Russell D, Cyster J, 2014: Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type Ⅰ interferon[J]. Science, 345, 679-684.
-
Sáiz M, De La Morena D, Blanco E, Núñez J, Fernández R, Sánchez-Vizcaíno J, 2003: Detection of foot-and-mouth disease virus from culture and clinical samples by reverse transcription-PCR coupled to restriction enzyme and sequence analysis[J]. Vet Res, 34, 105-117. doi: 10.1051/vetres:2002059
-
Shibata N, Carlin A, Spann N, Saijo K, Morello C, McDonald J, Romanoski C, Maurya M, Kaikkonen M, Lam M, Crotti A, Reichart D, Fox J, Quehenberger O, Raetz C, Sullards M, Murphy R, Merrill A, Brown H, Dennis E, Fahy E, Subramaniam S, Cavener D, Spector D, Russell D, Glass C, 2013: 25-Hydroxycholesterol activates the integrated stress response to reprogram transcription and translation in macrophages[J]. J Biol Chem, 288, 35812-35823. doi: 10.1074/jbc.M113.519637
-
Shrivastava-Ranjan P, Bergeron É, Chakrabarti A, Albariño C, Flint M, Nichol S, Spiropoulou C, 2016: 25-Hydroxycholesterol inhibition of lassa virus infection through aberrant GP1 glycosylation[J]. mBio, 7, e01808-16.
-
Venkataraman S, Reddy S, Loo J, Idamakanti N, Hallenbeck P, Reddy V, 2008: Structure of Seneca Valley virus-001: an oncolytic picornavirus representing a new genus[J]. Structure, 16, 1555-1561. doi: 10.1016/j.str.2008.07.013
-
Wu T, Ma F, Ma X, Jia W, Pan E, Cheng G, Chen L, Sun C, 2018: Regulating innate and adaptive immunity for controlling SIV infection by 25-hydroxycholesterol[J]. Front Immunol, 9, 2686-. doi: 10.3389/fimmu.2018.02686